26 April 2024
THIS ANNOUNCEMENT CONTAINS INSIDE
INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU NO.
596/2014) AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE
EUROPEAN UNION (WITHDRAWAL) ACT 2018 (AS AMENDED) ("MAR"). UPON THE
PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION
SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE
PUBLIC DOMAIN.
MOLECULAR ENERGIES
PLC
("Molecular" or the "Company")
Last Day of Dealings on
AIM
Post Cancellation Shareholder
Communications
Molecular Energies plc (AIM:
MEN), provides an update on the matters described in the circular
to shareholders dated 28 March 2024 and further information on
shareholder communication following cancellation of the admission
of the Company's ordinary shares to trading on AIM ("Cancellation").
Cancellation of admission to AIM
Cancellation will take place at 7.00
a.m. on 29 April 2024. The final day of dealings in the Company's
shares on AIM is today, 26 April 2024.
Website
The current format of the website of
the Company will be re-structured and will be live with effect from
1 May 2024.
The website will provide up to date
information with regard to all material developments of the Company
and members of its group. Whilst some sections of the current
website will no longer be applicable, in order to promote
transparency as a private company new features will be added with
the aim of strengthening the connection between the Company and its
remaining shareholders.
Communication
Molecular recognises that as a
private company, it is imperative to ensure that those who came on
its journey are kept regularly informed.
Accordingly, Molecular will publish
news of all material developments both on its website and via its
social media accounts, which it will continue to maintain. A
regular newsletter providing business updates will be issued with
the first anticipated by 30 September 2024, by which date the
Company anticipates that it will publish its annual accounts for
the year ended 31 December 2023. The Company will maintain its
shareholder communications email address -
info@molecularenergiesplc.com
- and investors wishing to receive these regular
updates or enter into dialogue with the Company are encouraged to
email that address requesting to sign up.
Dealing Arrangements
The Company's ordinary shares will
be admitted to trading on the JP Jenkins securities matching
platform from the 29 April 2024.
JP Jenkins provides a securities
matching venue for unlisted or unquoted assets in companies,
enabling shareholders and prospective investors to buy and sell
shares on a matched bargain basis. JP Jenkins is a trading name of
InfinitX Limited and Appointed Representative of Prosper Capital
LLP (FRN453007).
Shareholders wishing to trade these
securities can do so through their stockbroker. Trades will be
conducted at a level that JP Jenkins is able to match a willing
seller and a willing buyer. Trades can be conducted, and limits can
be accepted, during normal business hours. Shareholders or
potential investors can place limits via their existing UK
regulated stockbroker.
The indicative pricing for the
ordinary Shares (ISIN: GB00BMT80K89), as well as the transaction
history, will be available on the JP Jenkins website
at (https://jpjenkins.com/company/molecular-energies/).
The provision of the matched bargain
facility will be kept under review by the Board and, in determining
whether to continue to offer a matched bargain facility, the
Company shall consider expected (and communicated) shareholder
demand for such a facility as well as the composition of the
Company's register of members and the costs to the Company and
shareholders.
Molecular Energies PLC
Peter Levine, Chairman
Rob Shepherd, Group FD
|
+44 (0)20 7016 7950
info@molecularenergiesplc.com
|
Cavendish Capital Markets Limited
(Nominated Adviser & Broker)
Simon Hicks
George Dollemore
|
+44 (0)20 7220 0500
|
Tavistock (Financial PR &
IR)
Simon Hudson, Nick Elwes, Saskia
Sizen
|
+44 (0)20 7920 3150
|
JP Jenkins (Matched Bargain
Settlement Facility)
Veronika Oswald -
Director
|
+44 (0)20 7469 0937
|
For the purposes of MAR, Article 2
of Commission Implementing Regulation (EU) 2016/1055 and the UK
version of such implementing regulation (as amended), the
person responsible for arranging for the release of this
Announcement on behalf of the Company is Peter Levine,
Chairman.